Experience in CMC and CGT manufacturing: development and production of viral vectors, cell therapies and plasmids; analytics; CDMO mgmt; fill-finish; cleanroom design, buildout, commissioning, etc.
Product & Process Development
Analytical Development
Facilities, Manufacturing, & Compliance
Quality Assurance
Project & Program Management
Regulatory Affairs
Diligence & Business Strategy
Scott has over 20 years experience working with viral vectors, vaccines and biologics in GMP environments. He has been responsible for cleanroom design and build out and commissioning of vector facilities, as well as the oversight of cell therapy, fill finish and manufacturing support departments.
Scott started his career at Merck and Co. where he worked on the development of an Adenovirus-based HIV vaccine and later, the development, optimization and validation of release assays for live virus vaccines. He then moved to Indiana University (IU) where he managed the IU Vector Production Facility (IUVPF), overseeing the GMP production and testing of Lentiviral and Retroviral vectors for the IUVPF and the National Gene Vector Laboratories (NGVL). While at the IUVPF he also managed the design, build and commissioning of a new viral vector GMP production and testing facility.
After leaving the IUVPF, Scott joined Cincinnati Children’s Hospital Medical Center (CCHMC) managing the GMP Vector Production Facility, Viral Vector Core and the Aseptic Processing Labs. Scott then moved to the University of Florida where he was the Director of Cell Therapy, Fill Finish and Manufacturing Support Operations for Florida Biologix and Brammer Bio. He was also responsible for the design of two new fill finish suites.
Most recently, Scott served as Vice President of Vector Operations at Orchard Therapeutics where he was one of the original ten members and responsible for viral vector development, GMP vector production, plasmid production, oversight of 10 CDMOs, due diligence, and facility design.
(Also including relevant presentations)
Dark Horse Consulting Group
Principal
Orchard Therapeutics
Vice President of Vector Operations
University of Florida/Florida Biologix/Brammer Bio
Director of Cell Therapy, Fill Finish and Manufacturing Support Operations
Cincinnati Children’s Hospital Medical Center
Manager of Viral Vector Core, Vector Production Facility and Aseptic Processing Laboratories
Indiana University Vector Production Facility
Manager
Merck and Co., Inc.
Project Scientist and Regulatory Coordinator
Western Michigan University
M.S. in Molecular Biology
Grand Valley State University
B.S. in Biological Sciences
.png)
